Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
GRAP | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 3.38E4 | Evidence | |||||
GRAP | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 3.04E4 | Evidence | |||||
GRAP | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 1.58E4 | Evidence |
![]() |
||||
GRAP | KIT | KIT: Mast/stem cell growth factor receptor precursor | 1.40E4 | Evidence |
![]() |
||||
GRAP | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 1.40E4 | Evidence | |||||
GRAP | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 7.29E3 | Evidence | |||||
GRAP | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 3.83E3 | Evidence | |||||
GRAP | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 1.25E3 | Evidence | |||||
GRAP | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 1.01E3 | Evidence | |||||
GRAP | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 414.0 | Evidence | |||||
GRAP | SOS1 | SOS1: Son of sevenless homolog 1 | 339.0 | Evidence |
![]() |
||||
GRAP | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 297.0 | Evidence | |||||
GRAP | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 296.0 | Evidence | |||||
GRAP | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 244.0 | Evidence | |||||
GRAP | EPS15 | EPS15, AF1P: Epidermal growth factor receptor substrate 15 | 142.0 | Evidence | |||||
GRAP | SHC2 | N/A | 118.0 | Evidence | |||||
GRAP | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 82.50 | Evidence | |||||
GRAP | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 65.80 | Evidence | |||||
GRAP | CSK | CSK: Tyrosine-protein kinase CSK | 61.00 | Evidence | |||||
GRAP | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 55.80 | Evidence | |||||
GRAP | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 55.80 | Evidence | |||||
GRAP | INSR | INSR: Insulin receptor precursor | 53.20 | Evidence | |||||
GRAP | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 53.20 | Evidence | |||||
GRAP | EPHA7 | EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor | 53.20 | Evidence | |||||
GRAP | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 50.00 | Evidence | |||||
GRAP | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 48.00 | Evidence |
![]() |
||||
GRAP | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 48.00 | Evidence | |||||
GRAP | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 37.90 | Evidence | |||||
GRAP | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 36.70 | Evidence | |||||
GRAP | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 36.40 | Evidence | |||||
GRAP | SYK | SYK: Tyrosine-protein kinase SYK | 33.80 | Evidence | |||||
GRAP | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 33.2 | Evidence | |||||
GRAP | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 32.90 | Evidence | |||||
GRAP | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 29.10 | Evidence | |||||
GRAP | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 27.00 | Evidence | |||||
GRAP | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 27.00 | Evidence | |||||
GRAP | LYN | LYN: Tyrosine-protein kinase Lyn | 26.00 | Evidence | |||||
GRAP | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 23.20 | Evidence | |||||
GRAP | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 20.70 | Evidence | |||||
GRAP | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 19.5 | Evidence | |||||
GRAP | HCK | N/A | 18.60 | Evidence | |||||
GRAP | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 17.80 | Evidence | |||||
GRAP | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 17.70 | Evidence | |||||
GRAP | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 17.70 | Evidence | |||||
GRAP | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 16.00 | Evidence | |||||
GRAP | NCK2 | NCK2: Cytoplasmic protein NCK2 | 11.40 | Evidence | |||||
GRAP | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 11.40 | Evidence | |||||
GRAP | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 9.29 | Evidence | |||||
GRAP | WASPIP | N/A | 8.33 | Evidence | |||||
GRAP | ADAM9 | ADAM9, KIAA0021, MCMP, MDC9, MLTNG: ADAM 9 precursor | 7.82 | Evidence | |||||
GRAP | ADAM28 | ADAM28, ADAM23, MDCL: ADAM 28 precursor | 7.82 | Evidence | |||||
GRAP | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 7.82 | Evidence | |||||
GRAP | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 7.42 | Evidence | |||||
GRAP | SLAMF1 | SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor | 7.30 | Evidence | |||||
GRAP | MS4A1 | MS4A1, CD20: B-lymphocyte antigen CD20 | 7.30 | Evidence | |||||
GRAP | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 7.05 | Evidence | |||||
GRAP | SORBS3 | SORBS3, SCAM1: Vinexin | 6.54 | Evidence | |||||
GRAP | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 6.54 | Evidence | |||||
GRAP | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 6.54 | Evidence | |||||
GRAP | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 6.32 | Evidence | |||||
GRAP | CRKL | CRKL: Crk-like protein | 6.31 | Evidence | |||||
GRAP | APS | SH2B2, APS: SH2B adapter protein 2 | 6.31 | Evidence | |||||
GRAP | CD2AP | CD2AP: CD2-associated protein | 6.31 | Evidence | |||||
GRAP | RPS6KB1 | N/A | 6.16 | Evidence | |||||
GRAP | LNK | SH2B3, LNK: SH2B adapter protein 3 | 6.11 | Evidence | |||||
GRAP | ANKK1 | ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein | 6.11 | Evidence | |||||
GRAP | FLT4 | VEGFR3 long form | 5.90 | Evidence | |||||
GRAP | DOCK1 | DOCK1: Dedicator of cytokinesis protein 1 | 5.89 | Evidence | |||||
GRAP | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 5.63 | Evidence | |||||
GRAP | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 5.54 | Evidence | |||||
GRAP | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 5.40 | Evidence | |||||
GRAP | MAP4K3 | MAP4K3, RAB8IPL1: Mitogen-activated protein kinase kinase kinase kinase 3 | 5.27 | Evidence | |||||
GRAP | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 5.04 | Evidence | |||||
GRAP | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 5.04 | Evidence | |||||
GRAP | VAV1 | VAV1, VAV: Proto-oncogene vav | 5.04 | Evidence | |||||
GRAP | MOS | MOS: Proto-oncogene serine/threonine-protein kinase mos | 4.56 | Evidence | |||||
GRAP | DOK4 | DOK4: Docking protein 4 | 4.56 | Evidence | |||||
GRAP | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 4.42 | Evidence | |||||
GRAP | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 4.27 | Evidence | |||||
GRAP | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 4.09 | Evidence | |||||
GRAP | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 3.83 | Evidence | |||||
GRAP | DOK1 | DOK1: Docking protein 1 | 3.83 | Evidence | |||||
GRAP | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 3.83 | Evidence | |||||
GRAP | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 3.83 | Evidence | |||||
GRAP | SOS2 | SOS2: Son of sevenless homolog 2 | 3.76 | Evidence | |||||
GRAP | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 3.70 | Evidence | |||||
GRAP | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 3.70 | Evidence | |||||
GRAP | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 3.6 | Evidence | |||||
GRAP | WEE1 | WEE1: Wee1-like protein kinase | 3.41 | Evidence | |||||
GRAP | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 3.41 | Evidence | |||||
GRAP | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 3.36 | Evidence | |||||
GRAP | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 3.36 | Evidence | |||||
GRAP | CDC2 | CDC2: Cell division control protein 2 homolog | 3.31 | Evidence | |||||
GRAP | PRKD3 | PRKD3, EPK2, PRKCN: Serine/threonine-protein kinase D3 | 3.31 | Evidence | |||||
GRAP | SASH1 | SASH1, KIAA0790, PEPE1: SAM and SH3 domain-containing protein 1 | 3.23 | Evidence | |||||
GRAP | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 3.18 | Evidence | |||||
GRAP | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 3.18 | Evidence | |||||
GRAP | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 3.05 | Evidence | |||||
GRAP | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 3.05 | Evidence | |||||
GRAP | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 2.91 | Evidence | |||||
GRAP | TRPV3 | TRPV3: Transient receptor potential cation channel subfamily V member 3 | 2.91 | Evidence | |||||
GRAP | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 2.91 | Evidence | |||||
GRAP | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 2.91 | Evidence | |||||
GRAP | C20orf75 | C20orf75: Uncharacterized protein C20orf75 precursor | 2.91 | Evidence | |||||
GRAP | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 2.91 | Evidence | |||||
GRAP | CNN3 | CNN3: Calponin-3 | 2.9 | Evidence | |||||
GRAP | K-ALPHA-1 | TUBA1B: Tubulin alpha-1B chain | 2.83 | Evidence | |||||
GRAP | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 2.76 | Evidence | |||||
GRAP | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 2.68 | Evidence |
![]() |
||||
GRAP | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 2.68 | Evidence | |||||
GRAP | L1CAM | L1CAM, CAML1, MIC5: Neural cell adhesion molecule L1 precursor | 2.60 | Evidence | |||||
GRAP | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 2.60 | Evidence | |||||
GRAP | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 2.60 | Evidence | |||||
GRAP | CNTN1 | CNTN1: Contactin-1 precursor | 2.60 | Evidence | |||||
GRAP | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 2.60 | Evidence | |||||
GRAP | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 2.60 | Evidence | |||||
GRAP | SYNJ1 | SYNJ1, KIAA0910: Synaptojanin-1 | 2.55 | Evidence | |||||
GRAP | PLD2 | PLD2: Phospholipase D2 | 2.47 | Evidence | |||||
GRAP | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 2.47 | Evidence | |||||
GRAP | SOCS5 | SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 | 2.43 | Evidence | |||||
GRAP | IRS1 | IRS1: Insulin receptor substrate 1 | 2.43 | Evidence | |||||
GRAP | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 2.43 | Evidence | |||||
GRAP | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 2.40 | Evidence | |||||
GRAP | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 2.24 | Evidence | |||||
GRAP | TBK1 | TBK1, NAK: Serine/threonine-protein kinase TBK1 | 2.24 | Evidence | |||||
GRAP | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 2.17 | Evidence | |||||
GRAP | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 2.17 | Evidence | |||||
GRAP | EPOR | EPOR: Erythropoietin receptor precursor | 2.17 | Evidence |
![]() |
||||
GRAP | IQSEC1 | IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein | 2.00 | Evidence | |||||
GRAP | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 1.96 | Evidence | |||||
GRAP | CHN2 | CHN2, ARHGAP3, BCH: Beta-chimaerin | 1.96 | Evidence | |||||
GRAP | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 1.96 | Evidence | |||||
GRAP | CDK5 | CDK5: Cell division protein kinase 5 | 1.96 | Evidence | |||||
GRAP | THY1 | THY1: Thy-1 membrane glycoprotein precursor | 1.94 | Evidence | |||||
GRAP | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 1.93 | Evidence | |||||
GRAP | ITGB4 | N/A | 1.91 | Evidence | |||||
GRAP | NCAM1 | NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor | 1.72 | Evidence | |||||
GRAP | ALCAM | ALCAM, MEMD: CD166 antigen precursor | 1.72 | Evidence | |||||
GRAP | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 1.69 | Evidence | |||||
GRAP | FNBP1 | N/A | 1.67 | Evidence | |||||
GRAP | B2M | B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro | 1.64 | Evidence | |||||
GRAP | SNX15 | SNX15: Sorting nexin-15 | 1.4 | Evidence | |||||
GRAP | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 1.17 | Evidence | |||||
GRAP | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 1.17 | Evidence |
![]() |
||||
GRAP | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 1.13 | Evidence | |||||
GRAP | RICS | RICS: Rac GTPase activating protein | 1.11 | Evidence |
![]() ![]() |
||||
GRAP | ADAM15 | ADAM15: ADAM15 isoform 6b | 1.07 | Evidence | |||||
GRAP | PTPRS | N/A | 1.07 | Evidence | |||||
GRAP | MET | N/A | 1.07 | Evidence | |||||
GRAP | ATP2A2 | ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 1.06 | Evidence | |||||
GRAP | ANKS1A | ANKS1A, ANKS1, KIAA0229: Ankyrin repeat and SAM domain-containing protein 1A | 1.04 | Evidence |